---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "RWXCyO1fzYKk1KpgDXKJhvM00dWL62N67fFT+2hJRhzyKUWDFP64rNfbWaGtsaSaZliLKF/O9vPAt9QkC27oYR8dz33508VCjGuIeBIlMjgK7ZiUUJswZiowrkm8SZwo7GAgWAYhRTu9XrJVBSIyv3Op9QjU8q9csOjxrnSJ71i4K80bPc7PHFJPRYVh1XfXFvDj9/6aw8DxIBC0VaV4JTTnFc1SAgW39zOspS8XnGyCFPpELabiTUiOKhM/sbeyb1UcH4QeojJgoVl9JHnzZRAsS+Ea4JQx3EytXSMSd9iSSmr8HAd9XYO+xL5gKg4tcDi1lIvKyo//vpN2ay7EZa3EsQw6Q6QZjm3bvvH0JJc=;ZmE1D9xNfqh7I6yMNcocnA=="
---

